OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
0125$0.3057

Sun Hing Vision Group Holdings Ltd

Medical Equipment, Supplies & DistributionVerified

Sun Hing Vision Group Holdings Ltd exhibits a weak capital structure and liquidity position, with a price-to-book ratio of 0.13 and a market cap of HKD 78.8 million, significantly below its book value. The company holds HKD 185.3 million in cash and equivalents, but this is offset by negative operating and free cash flows of HKD -66.7 million and HKD -21.0 million, respectively, indicating operational cash outflows. Profitability metrics are negative, with a return on equity of -5.12% and a return on assets of -3.61%, both well below the industry norms for Medical Equipment, Supplies & Distribution. The company reported a net loss of HKD 32.2 million and an operating loss of HKD 40.3 million, reflecting poor performance in its core operations. The company operates through two segments: Eyewear Products and Trademarks. The Eyewear Products segment is involved in manufacturing and trading, while the Trademarks segment focuses on licensing. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the performance of each business line. Geographically, the company's exposure is not disclosed, but the lack of diversification could pose a risk if demand for eyewear or trademark licensing declines in key markets. The company's growth trajectory is uncertain, with no clear indication of revenue growth in the current or next fiscal year. The negative operating and free cash flows suggest that the company may struggle to fund expansion or innovation without external financing. The absence of capital expenditures in the latest period also indicates a lack of investment in growth initiatives. Risk factors include liquidity concerns, as the company has negative operating cash flow and a low liquidity score. However, the risk of dilution is currently low, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.08 suggests a conservative capital structure, but the negative net income and operating cash flow could pressure liquidity if the trend continues. Recent events and filings do not indicate any material changes in the company's operations or financial position. The absence of significant capital expenditures and the lack of segment-specific revenue data suggest that the company may not be actively pursuing growth strategies.

30-day price · 0125-0.04 (-11.8%)
Low$0.29High$0.35Close$0.30As of22 May, 00:00 UTC
Profile
CompanySun Hing Vision Group Holdings Ltd
Ticker0125.HK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Sun Hing Vision Group Holdings Ltd operates in the eyewear and trademark licensing sectors, generating revenue through the manufacturing and trading of eyewear products and the granting of trademark licenses.

Classification. The company is classified under the Healthcare Services & Equipment business sector within the Healthcare economic sector, with a confidence level of 0.92.

Sun Hing Vision Group Holdings Ltd exhibits a weak capital structure and liquidity position, with a price-to-book ratio of 0.13 and a market cap of HKD 78.8 million, significantly below its book value. The company holds HKD 185.3 million in cash and equivalents, but this is offset by negative operating and free cash flows of HKD -66.7 million and HKD -21.0 million, respectively, indicating operational cash outflows. Profitability metrics are negative, with a return on equity of -5.12% and a return on assets of -3.61%, both well below the industry norms for Medical Equipment, Supplies & Distribution. The company reported a net loss of HKD 32.2 million and an operating loss of HKD 40.3 million, reflecting poor performance in its core operations. The company operates through two segments: Eyewear Products and Trademarks. The Eyewear Products segment is involved in manufacturing and trading, while the Trademarks segment focuses on licensing. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the performance of each business line. Geographically, the company's exposure is not disclosed, but the lack of diversification could pose a risk if demand for eyewear or trademark licensing declines in key markets. The company's growth trajectory is uncertain, with no clear indication of revenue growth in the current or next fiscal year. The negative operating and free cash flows suggest that the company may struggle to fund expansion or innovation without external financing. The absence of capital expenditures in the latest period also indicates a lack of investment in growth initiatives. Risk factors include liquidity concerns, as the company has negative operating cash flow and a low liquidity score. However, the risk of dilution is currently low, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.08 suggests a conservative capital structure, but the negative net income and operating cash flow could pressure liquidity if the trend continues. Recent events and filings do not indicate any material changes in the company's operations or financial position. The absence of significant capital expenditures and the lack of segment-specific revenue data suggest that the company may not be actively pursuing growth strategies.
Key takeaways
  • Sun Hing Vision Group Holdings Ltd is operating at a loss with negative returns on equity and assets.
  • The company's liquidity position is weak, with negative operating and free cash flows.
  • There is no clear indication of growth in the current or next fiscal year.
  • The risk of dilution is currently low, but the company's financial performance could change this outlook.
  • The company's segment and geographic revenue breakdown is not disclosed, limiting visibility into its business drivers.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$828.5M
Gross profit$93.8M
Operating income-$40.3M
Net income-$32.2M
R&D
SG&A
D&A
SBC
Operating cash flow-$66.7M
CapEx-$10.3M
Free cash flow-$21.0M
Total assets$893.0M
Total liabilities$263.0M
Total equity$630.0M
Cash & equivalents$185.3M
Long-term debt$50.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$828.5M-$40.3M-$32.2M-$21.0M
FY-1$702.3M-$35.1M-$28.4M-$22.5M
FY-2$704.9M-$32.7M-$30.6M-$18.1M
FY-3$876.7M$11.0M$9.1M$6.2M
FY-4$701.7M$4.5M$9.6M$7.0M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$893.0M$630.0M$185.3M
FY-1$906.0M$670.4M$274.5M
FY-2$945.2M$722.4M$328.8M
FY-3$1.04B$781.5M
FY-4$1.07B$770.1M
PeriodOCFCapExFCFSBC
FY0-$66.7M-$10.3M-$21.0M
FY-1-$25.8M-$11.3M-$22.5M
FY-2$33.5M-$9.3M-$18.1M
FY-3$45.2M-$16.7M$6.2M
FY-4$44.0M-$24.8M$7.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.30
Market cap$78.8M
Enterprise value-$56.3M
P/E
Reported non-GAAP P/E
EV/Revenue-0.1
EV/Op income
EV/OCF
P/B0.1
P/Tangible book0.1
Tangible book$630.0M
Net cash$135.2M
Current ratio2.2
Debt/Equity0.1
ROA-3.6%
ROE-5.1%
Cash conversion2.1%
CapEx/Revenue-1.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric0125Activity
Op margin-4.9%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-3.9%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin11.3%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-1.2%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity8.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 02:13 UTC#fae6b0dc
Market quoteclose HKD 0.30 · shares 0.26B diluted
no public URL
2026-05-05 02:13 UTC#40bf8968
Source: analysis-pipeline (hybrid)Generated: 2026-05-05 02:14 UTCJob: f10f30e9